Peds SIG: Duchenne Muscular Dystrophy and the Physical Therapistís Role Throughout the Ambulatory Disease Phases

2/8/2022
7:00 PM – 8:30 PM

virtual on Zoom
link will be sent on day of event

Register

This educational session is the fourth in the APTA CT Pediatric SIG’s 2021-2022 series on Pediatric Neuromuscular Diseases.  Delivered virtually over the Zoom platform, Dr. Fidler will present a PowerPoint-based overview of Duchenne muscular dystrophy (DMD), with a focus on the ambulatory phases of the disease progression, discussing relevant outcome measures, treatment interventions, and the physical therapist’s role in disease management.  This session will be followed in early spring by a multidisciplinary panel format session on non-ambulatory DMD.    

Objectives

Attendees will be able to: 

  1. Describe key features of the early and late ambulatory stages in Duchenne muscular dystrophy (DMD).
  2. Identify three outcome measures useful with ambulatory boys with DMD.
  3. Describe two indicators/predictors of disease progression in boys with DMD.
  4. Describe two key exercises/interventions for each ambulatory stage of DMD.
  5. Describe two benefits of the multidisciplinary team approach to DMD management.

John (“Jack”) Fidler is a Mobility Territory Manager for Permobil. He received his Bachelor’s degree in Exercise Science and his Doctorate of Physical Therapy from the University of Connecticut. He is a Rehabilitation Engineering Society of North America (RESNA) -certified Assistive Technology Professional (ATP).  He had five years of clinical experience in developmental pediatric physical therapy practice at Yale New Haven Children’s Hospital (YNHCH), where he was a treating therapist in the Neuromuscular Clinic and a Clinical Evaluator for Yale University’s Duchenne muscular dystrophy pharmacologic clinical trials, prior to joining Permobil.


Sign up to Receive Updates ›  APTA

CTAPTA Liberty Square Group
4 Liberty Sq, #500
Boston, MA 02109
(857) 702 – 9915
ctapta@libertysquaregroup.com